Mepsgen - About the company
Mepsgen is a series C company based in Seoul (South Korea), founded in 2019 by . It operates as a Developer of human organ model chips for pharmaceutical development. Mepsgen has raised $29.3M in funding from investors like Korean Development Bank, and SBI Investment Korea. The company has 29 active competitors, including 14 funded and 1 that has exited. Its top competitors include companies like Emulate, CN Bio and AxoSim.
Company Details
Developer of human organ model chips for pharmaceutical development. The company develops and produces a 3D cell cultures organ-on-a-chip platform such as the MEPS-X series and MG-X series to develop drug candidates which target Alzheimer's and brain tumors.
- Website
- Email ID
- @mepsgen.com
- Phone Number
- +82
Key Metrics
Founded Year
2019
Location
Seoul, South Korea
Stage
Series C
Total Funding
in 4 rounds
Latest Funding Round
Investors
Ranked
7th among 29 active competitors
Similar Companies
Emulate &
Get your free copy of Mepsgen's company profile
Mepsgen's funding and investors
Mepsgen has raised a total funding of $29.3M over 4 rounds. Its first funding round was on Aug 2020. Its latest funding round was a Series C round on Nov 19, 2024 for $14.8M. 5 investors participated in its latest round, which includes Korea Investment Holdings, SBI Investment Korea, E&Investment and KB Investment.
Mepsgen has 7 institutional investors including Korean Development Bank, and SBI Investment Korea. There is only 1 Angel Investor in Mepsgen.
Here is the list of recent funding rounds of Mepsgen:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Nov 19, 2024 | $14.8M | Series C | 9659772 | 6458261 | , KB Investment, and |
Jul 2022 | $8.02M | Series B | 4691023 | 4725952 | - |
Aug 2021 | $3.47M | Series A | 2547134 | 2854880 | - |
Access funding benchmarks and valuations. Sign up today!View details of Mepsgen's funding rounds and investors
Mepsgen's founders and board of directors
The founders of Mepsgen is . is the CEO of Mepsgen.
View details of Mepsgen's Founder profiles and Board Members
Mepsgen's Competitors and alternates
Top competitors of Mepsgen include Emulate, CN Bio and AxoSim. Here is the list of Top 10 competitors of Mepsgen, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st | Emulate 2013, Boston (United States), Series E | Developer of in vitro models for drug development | $225M | Perceptive Advisors, ATEL Capital GroupÌý&²¹³¾±è;Ìý | 66/100 |
2nd | CN Bio 2009, Cambridge (United Kingdom), Series B | Develops organ-on-a-chip platforms for drug discovery | $44.8M | , Ìý&²¹³¾±è;Ìý | 59/100 |
3rd | AxoSim 2014, New Orleans (United States), Series A | Advancing nerve-on-a-chip technology to improve drug development. | $6.78M | 57/100 | |
4th | Mimetas 2013, Leiden (Netherlands), Series B | Develops microfluidics-based organ-on-a-chip tissue models | $28.9M | , EIC FundÌý&²¹³¾±è;Ìý | 55/100 |
5th | Nortis 2007, Woodinville (United States), Acquired | Developer of platform for generating small segments of human tissues and organs in microfluidic chips | $10.7M | Emerging Technology Partners, Corewell Health VenturesÌý&²¹³¾±è;Ìý | 49/100 |
6th | Developer of microfluidic devices for industrial applications | $8.89M | 47/100 | ||
7th |  Mepsgen 2019, Seoul (South Korea), Series C | Developer of human organ model chips for pharmaceutical development | $29.3M | Korea Investment Holdings, SBI Investment KoreaÌý&²¹³¾±è;Ìý | 38/100 |
8th | _1574840379393.png?height=40&width=40){kind=logo} Obatala Sciences 2017, New Orleans (United States), Series A | Provider of research enabling products and services to research centers | $3.53M | Springboard Enterprises, Reform VenturesÌý&²¹³¾±è;Ìý | 45/100 |
9th |  Cellbox Labs 2020, Riga (Latvia), Seed | Provider of organ-on-chip platform for drug discovery and development | $1.01M | 42/100 | |
10th |  Hesperos 2015, Orlando (United States), Funding Raised | Developer of organ-on-a-chip solutions for preclinical testing | - | 42/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Mepsgen's competitors? Click to see the top ones
Mepsgen's Investments and acquisitions
Mepsgen has made no investments or acquisitions yet.
Reports related to Mepsgen
Here is the latest report on Mepsgen's sector:
View
News related to Mepsgen
Media has covered Mepsgen for 1 event in last 1 year.
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about Mepsgen
When was Mepsgen founded?
Mepsgen was founded in 2019.Where is Mepsgen located?
Mepsgen is located in Seoul, South Korea.Is Mepsgen a funded company?
Mepsgen is a funded company, its first funding round was on Aug 2020.When was the latest funding round of Mepsgen?
Mepsgen's latest funding round was on Nov 19, 2024.What is the annual revenue of Mepsgen?
Annual revenue of Mepsgen is undefined as on undefined.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Cover Summon - Seoul based, 2018 founded, Series A company
- G C Zarnas & Co. Inc - Bethlehem based, 1948 founded, Unfunded company
- Strata Manufacturing - Al Ain based, 2009 founded, Funding Raised company
- general mechanical - Auburn based, 2002 founded, Unfunded company
- Gibbons Extreme Insulation - Indianapolis based, 1978 founded, Unfunded company
- Guaranty Glass Co - Worcester based, 2010 founded, Unfunded company
